Literature DB >> 17636367

A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies.

Kiren K Ubhi1, Hassan Shaibah, Tracey A Newman, David Shepherd, Amritpal Mudher.   

Abstract

Hyperphosphorylation and aggregation of tau into tangles is a feature of disorders such as Alzheimer's disease and other Tauopathies. To model these disorders in Drosophila melanogaster, human tau has been over-expressed and a variety of phenotypes have been observed including neurotoxicity, disrupted neuronal and synaptic function and locomotor impairments. Neuronal dysfunction has been seen prior to neuronal death and in the absence of tangle formation. The Drosophila tau protein shares a large degree of homology with human tau but differs in the crucial microtubule binding domains. Although like human tau Drosophila tau can induce neurotoxicity, little is known about its ability to disrupt neuronal function. In this study we demonstrate that like human tau, over-expression of Drosophila tau results in disrupted axonal transport, altered neuromuscular junction morphology and locomotor impairments. This indicates that like human tau, over-expression of Drosophila tau compromises neuronal function despite significant differences in microtubule binding regions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636367     DOI: 10.1007/s10158-007-0052-4

Source DB:  PubMed          Journal:  Invert Neurosci        ISSN: 1354-2516


  27 in total

1.  Cell type-specific processing of human Tau proteins in Drosophila.

Authors:  Sofia Grammenoudi; Stylianos Kosmidis; Efthimios M C Skoulakis
Journal:  FEBS Lett       Date:  2006-07-21       Impact factor: 4.124

Review 2.  Tau aggregation is driven by a transition from random coil to beta sheet structure.

Authors:  Martin von Bergen; Stefan Barghorn; Jacek Biernat; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  Biochim Biophys Acta       Date:  2004-11-12

3.  Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model.

Authors:  Bin Zhang; Arpita Maiti; Sharon Shively; Fara Lakhani; Gaye McDonald-Jones; Jennifer Bruce; Edward B Lee; Sharon X Xie; Sonali Joyce; Chi Li; Philip M Toleikis; Virginia M-Y Lee; John Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

4.  Study of tauopathies by comparing Drosophila and human tau in Drosophila.

Authors:  Xinping Chen; Yan Li; Junbo Huang; Dawei Cao; Guoying Yang; Weijie Liu; Huimin Lu; Aike Guo
Journal:  Cell Tissue Res       Date:  2007-04-04       Impact factor: 5.249

5.  Identification and characterization of the Drosophila tau homolog.

Authors:  G Heidary; M E Fortini
Journal:  Mech Dev       Date:  2001-10       Impact factor: 1.882

6.  Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila.

Authors:  Olivier Blard; Sébastien Feuillette; Jacqueline Bou; Boris Chaumette; Thierry Frébourg; Dominique Campion; Magalie Lecourtois
Journal:  Hum Mol Genet       Date:  2007-02-19       Impact factor: 6.150

7.  Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions.

Authors:  Francis C Chee; Amritpal Mudher; Matthew F Cuttle; Tracey A Newman; Daniel MacKay; Simon Lovestone; David Shepherd
Journal:  Neurobiol Dis       Date:  2005-07-14       Impact factor: 5.996

8.  GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila.

Authors:  A Mudher; D Shepherd; T A Newman; P Mildren; J P Jukes; A Squire; A Mears; J A Drummond; S Berg; D MacKay; A A Asuni; R Bhat; S Lovestone
Journal:  Mol Psychiatry       Date:  2004-05       Impact factor: 15.992

9.  Learning and memory deficits upon TAU accumulation in Drosophila mushroom body neurons.

Authors:  Andreas Mershin; Elias Pavlopoulos; Olivia Fitch; Brittany C Braden; Dimitri V Nanopoulos; Efthimios M C Skoulakis
Journal:  Learn Mem       Date:  2004 May-Jun       Impact factor: 2.460

10.  The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.

Authors:  Florian Plattner; Marco Angelo; K Peter Giese
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

View more
  14 in total

1.  A Drosophila model of spinal muscular atrophy uncouples snRNP biogenesis functions of survival motor neuron from locomotion and viability defects.

Authors:  Kavita Praveen; Ying Wen; A Gregory Matera
Journal:  Cell Rep       Date:  2012-06-21       Impact factor: 9.423

Review 2.  The power and richness of modelling tauopathies in Drosophila.

Authors:  Katerina Papanikolopoulou; Efthimios M C Skoulakis
Journal:  Mol Neurobiol       Date:  2011-06-17       Impact factor: 5.590

3.  The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicity in Vivo.

Authors:  Engie Prifti; Eleni N Tsakiri; Ergina Vourkou; George Stamatakis; Martina Samiotaki; Katerina Papanikolopoulou
Journal:  J Neurosci       Date:  2020-12-17       Impact factor: 6.167

Review 4.  Alzheimer's disease and tauopathy studies in flies and worms.

Authors:  Jill Wentzell; Doris Kretzschmar
Journal:  Neurobiol Dis       Date:  2010-03-17       Impact factor: 5.996

5.  Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.

Authors:  Oyinkan Sofola; Fiona Kerr; Iain Rogers; Richard Killick; Hrvoje Augustin; Carina Gandy; Marcus J Allen; John Hardy; Simon Lovestone; Linda Partridge
Journal:  PLoS Genet       Date:  2010-09-02       Impact factor: 5.917

6.  Modelling tauopathies in Drosophila: insights from the fruit fly.

Authors:  Catherine M Cowan; Megan A Sealey; Shmma Quraishe; Marie-Therese Targett; Kristen Marcellus; Douglas Allan; Amritpal Mudher
Journal:  Int J Alzheimers Dis       Date:  2011-12-29

7.  Drosophila models of tauopathies: what have we learned?

Authors:  Marc Gistelinck; Jean-Charles Lambert; Patrick Callaerts; Bart Dermaut; Pierre Dourlen
Journal:  Int J Alzheimers Dis       Date:  2012-06-04

Review 8.  Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection.

Authors:  Steven D Buckingham; Andrew K Jones; Laurence A Brown; David B Sattelle
Journal:  Pharmacol Rev       Date:  2009-03-16       Impact factor: 25.468

9.  Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer's disease-related tau phosphorylation via PAR-1.

Authors:  Kanae Iijima-Ando; Michiko Sekiya; Akiko Maruko-Otake; Yosuke Ohtake; Emiko Suzuki; Bingwei Lu; Koichi M Iijima
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

10.  Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.

Authors:  Bidisha Roy; George R Jackson
Journal:  Hum Mol Genet       Date:  2014-01-14       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.